Xarelto 50458-0575
Generic: Rivaroxaban
Product NDC
50458-0575- Manufacturer
- Janssen Pharmaceuticals, Inc.
- Dosage Form
- Granule, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 1, 2021
- Listing Expires
- December 31, 2027
- Application
- NDA215859
Need to source Xarelto? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rivaroxaban | 155 mg/1 |
Drug Class
Factor Xa Inhibitor [EPC]Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]
Packaging Options(1)
1 BOTTLE in 1 CARTON (50458-575-01) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE